Dr. Jacob Lalezari, Chief Executive Officer of CytoDyn (CYDY), talks to our hosts about the company’s cancer research programs, clinical trial progress, the development of leronlimab, and CytoDyn’s plans for future growth and partnerships.
February 7, 2023
